Gubra reveals early data for once-weekly obesity asset
13 Nov 2024 //
FIERCE BIOTECH
Boehringer and Gubra announce clinical development of first-in-class Treatment
01 Jul 2024 //
PRESS RELEASE
13 Nov 2024 //
FIERCE BIOTECH
01 Jul 2024 //
PRESS RELEASE